Insights On Trial Design
-
A Patient-Centric Approach To eConsent
8/23/2023
Discover how electronic consent solutions centered around patients' needs can effectively alleviate challenges for both patients and research sites.
-
Clinical Research Considerations For Rare Disease Patients: Part 2 — The Impact Of Physician And Site Support
12/12/2022
Our industry must examine whether — and how — we support physicians and clinical trial sites, who work under constant pressure related to timelines, data quality, and patient care.
-
How To Avoid Selection Bias Through Proactive Action
6/6/2022
Learn how drug makers worldwide need to ensure that conditions for bias are not created as a result of access to devices or WiFi when it comes to clinical research.
-
The Impact Of Inclusion/Exclusion Criteria On Clinical Trial Diversity
5/13/2023
The industry is aware of the racial and ethnic imbalance in clinical trials and its consequences. Discover how inclusive trial design can lead to better patient outcomes and more representative results.
-
Supporting Utilization & Recruitment Through COVID-19
6/7/2023
Supporting one of the world's largest pharmaceutical research organizations, MRN has more than doubled patient recruitment rates and quadrupled home visit referrals during the global outbreak of COVID-19.
-
This Is How We Positively Disrupt Clinical Research
10/23/2023
Leverage three key lessons from the 15th annual Clinical Operations Retreat for Executives (CORE East) where life science executives discussed how to collectively improve the business and approach to clinical development.
-
Patient First Solutions For Oncology
2/14/2023
Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.
-
Patient Retention: Quality Of Life Is Key
11/20/2023
Sponsors working to address the dropout rate for Phase 3 clinical trials should review this insight on how to be more mindful of the patient's quality of life and how that can boost retention.
-
Return Of Research Results To Study Participants
7/20/2022
Discover why empirical research into participant views and experiences has consistently shown participants' desire to learn the results of research to which they’ve contributed.
-
Medidata AI - Using Data to Accelerate Racial Diversity in US Clinical Trials
11/2/2022
Historically, US clinical trials have been shown to recruit disproportionately large percentages of White patients, raising concerns about the generalizability of clinical trial results to underrepresented racial minority patient populations. Because of this, the FDA has recently reiterated its guidance stating that clinical trials need to reflect the demographic distribution of the US.